Section 337 intellectual property enforcement actions before the International Trade Commission (“ITC”) continue to gain in popularity....more
TEVA PHARMACEUTICALS: IS IT TIME TO RETHINK HOW YOU WILL ARGUE CLAIM CONSTRUCTION?
The United States Supreme Court decided in Teva Pharmaceuticals USA Inc. v. Sandoz Inc. that the Federal Circuit must review all...more
3/31/2015
/ Claim Construction ,
Clear Error Standard ,
De Novo Standard of Review ,
Extrinsic Evidence ,
Indefiniteness ,
Nautilus Inc. v. Biosig Instruments ,
Patent Infringement ,
Patents ,
SCOTUS ,
Standard of Review ,
Teva Pharmaceuticals ,
Teva v Sandoz
In This Issue:
- AMERICA INVENTS ACT FINAL IMPLEMENTATION: FROM FIRST-TO-INVENT TO FIRST-TO-FILE:
The America Invents Act (“AIA”), which went into effect September 16, 2011, introduces some of the most...more
3/25/2013
/ America Invents Act ,
Apple ,
DNA ,
First-to-File ,
First-to-Invent ,
Human Genes ,
Patent Applications ,
Patent Reform ,
Patent-Eligible Subject Matter ,
Patents ,
Retailers ,
SCOTUS ,
Trademarks ,
USPTO